Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Myasthenia Gravis × Steroids × Clear all

Phase

Status

Sponsor Class

Study Type

Observational 2 Interventional 1

Sponsor

Conditions

Multiple Myeloma 7 Prostatic Neoplasms 3 Plasmacytoma 2 Paraproteinemias 2 Neoplasm Metastasis 2 Leukemia, Plasma Cell 2 Breast Neoplasms 2 Spinal Cord Compression 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms 1 Myasthenia Gravis 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Follicular 1 Lymphoma 1 Hepatitis 1 Hemangioma 1 Head and Neck Neoplasms 1 Gallstones 1 Common Bile Duct Neoplasms 1 Common Bile Duct Diseases 1 Colorectal Neoplasms 1 Chemical and Drug Induced Liver Injury 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma, Hepatocellular 1 Bone Cysts 1 Anatomic Stage IV Breast Cancer AJCC v8 1 Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

rozanolixizumab 9 zilucoplan 7 efgartigimod alfa 6 Rituximab 6 telitacicept 5 eculizumab 5 Prednisone 5 Cyclophosphamide 5 fludarabine 4 Pyridostigmine Bromide 4 Hizentra 4 ravulizumab 3 Tacrolimus 3 HBM9161 3 Amifampridine 3 thymoglobulin 2 inebilizumab 2 Prednisolone 2 Mycophenolic Acid 2 Immunoglobulins, Intravenous 2 tofacitinib 1 tocilizumab 1 satralizumab 1 sargramostim 1 rhoA GTP-Binding Protein 1 remibrutinib 1 prednylidene 1 iptacopan 1 gamma-Globulins 1 deltacortene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00995722 2017-06-02

EPITOME'

University of Miami

Phase 3 Terminated

11 enrolled 14 charts

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡